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OBJECTIVE — Insulin resistance and -cell function are major predictors of type 2 diabetes,
but studies using direct methods of insulin resistance and secretion are few and relatively small.
Furthermore,thestrengthoftheseassociationshasnotbeentestedindifferentethnicgroupsand
various states of glucose tolerance, family history of diabetes, and obesity.
RESEARCH DESIGN AND METHODS — Predictors of incident diabetes were evalu-
ated in Hispanic, non-Hispanic white, and African American participants in the Insulin Resis-
tance Atherosclerosis Study (aged 40–69 years). In 557 participants with normal glucose
tolerance and 269 with impaired glucose tolerance (IGT), insulin sensitivity (insulin sensitivity
index [SI]) and ﬁrst-phase insulin secretion (acute insulin response [AIR]) were directly mea-
sured using the frequently sampled intravenous glucose tolerance test.
RESULTS — At the 5-year follow-up examination, 128 (15.5%) individuals had developed
diabetes.BothSI(oddsratio1SD0.50[95%CI0.37–0.68])andAIR(0.51[0.40–0.65])were
independent predictors of incident diabetes even after adjustment for age, sex, ethnicity, center,
IGT, family history of diabetes, and BMI. The strength of the relation of SI and AIR to incident
diabetes was not signiﬁcantly affected by potential interactions of age, sex, ethnicity, glucose
tolerance, BMI, or family history of diabetes (P  0.15).
CONCLUSIONS — Both insulin sensitivity and -cell function predict conversion to dia-
betesindifferentethnicgroupsandvariousstatesofglucosetolerance,familyhistoryofdiabetes,
and obesity. The prevention of type 2 diabetes should focus on interventions that improve both
insulin resistance and insulin secretion.
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nsulin resistance and insulin secretion
are major predictors of type 2 diabetes,
but much of the evidence is the result
of studies that use surrogate measures of
insulin resistance and -cell function
(1–4). There are few studies that have
measuredinsulinresistanceandsecretion
bydirectmethods.Thesestudieshaveen-
rolledrelativelyfewparticipantsandhave
targeted individuals from a single ethnic
group. In the study by Martin et al. (5),
there were 25 incident cases of diabetes
among 151 offspring of white parents
who both had type 2 diabetes. In a subse-
quent report by Goldﬁne et al. (6), this
cohort of individuals was compared with
a cohort of 181 subjects with normal glu-
cosetolerance(NGT)withonly6incident
casesofdiabetesduringameanfollow-up
of 25 years (6). In the Pima Indian report,
200 subjects were studied and 38 devel-
oped type 2 diabetes (7). In a more recent
study from the Netherlands, 101 white
individuals with impaired glucose toler-
ance (IGT) were enrolled and 35 devel-
oped diabetes (8). Risk of progression to
IGT and diabetes associated with direct
measures of insulin sensitivity and secre-
tion was also examined in 399 Pima Indi-
ans (9) and in 81 ﬁrst-degree relatives of
African Americans with type 2 diabetes
(10). None of these studies adjusted their
results for glucose tolerance status and
adiposity. Furthermore, there are few
data on how insulin resistance and secre-
tion perform in different ethnic groups
and various states of glucose tolerance,
family history of diabetes, and obesity.
Because the signiﬁcance of insulin re-
sistance and secretion could differ by eth-
nic group, parental history of diabetes,
and obesity, we examined the heteroge-
neity of the relation of insulin resistance
and -cell function to future develop-
ment of type 2 diabetes. The Insulin
ResistanceAtherosclerosisStudy(IRAS)isa
large epidemiological study on insulin re-
sistance and cardiovascular risk factors
among individuals of three ethnic groups
(African Americans, Hispanics, and non-
Hispanic whites) (11). Insulin sensitivity
and ﬁrst-phase insulin secretion were di-
rectlymeasuredusingthefrequentlysam-
pled intravenous glucose tolerance test
with MINMOD analysis.
RESEARCH DESIGN AND
METHODS— The IRAS is a multi-
center observational epidemiological
study of the relationships among insulin
resistance, cardiovascular disease, and its
known risk factors in different ethnic
groups and various states of glucose tol-
erance. The design and methods of this
studyhavebeendescribedindetailinpre-
viouspublications(11).Inbrief,thestudy
was conducted at four clinical centers. At
centers in Oakland and Los Angeles, Cal-
ifornia, non-Hispanic whites and African
Americans were recruited from Kaiser
Permanente, a nonproﬁt HMO. Centers
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ley, Colorado, recruited Hispanics from
two ongoing population-based studies
(theSanAntonioHeartStudyandtheSan
Luis Valley Diabetes Study). A total of
1,625 individuals participated in the
baseline IRAS examination (56%
women), which occurred between Octo-
ber1992andApril1994.Afteranaverage
of 5.2 years (range 4.5–6.6 years), fol-
low-up examinations of this cohort were
conducted using the baseline protocol.
The response rate was 81%, and those
who attended the follow-up examination
were similar to those who did not attend
intermsofethnicity,sex,baselineglucose
tolerance status, and BMI (all compari-
sons, P  0.32). The IRAS protocol was
approved by local institutional review
committees,andallparticipantsprovided
written informed consent.
Participants who were alive at the
time of the follow-up visit were eligible
foranalysisiftheywerenondiabeticatthe
time of enrollment (n  1,043). We ex-
cluded 217 participants (failure to return
to the follow-up visit in 153 individuals
and information unavailable on variables
of interest in 64 individuals). Therefore,
the present report includes information
on 826 (79.2%) participants (332 non-
Hispanic whites, 206 African Americans,
and 288 Hispanics). Participants who
were eligible for analysis had baseline
characteristics (e.g., age, ethnicity, sex,
glucose tolerance status, BMI, waist cir-
cumference, and insulin sensitivity index
[SI]; all comparisons, P  0.2) similar to
thoseofparticipantswhowereexcludedex-
cept for acute insulin response (AIR)
(higher in eligible participants, P  0.005).
Clinical measurements and
procedures
The IRAS protocol required two visits, 1
week apart, of 4 h each. Protocols were
identical at the baseline and 5-year fol-
low-up examinations. Subjects were
asked before each visit to fast for 12 h, to
abstain from heavy exercise and alcohol
for 24 h, and to refrain from smoking on
the morning of the examination. During
the ﬁrst baseline and follow-up visits, a
75-g oral glucose tolerance test was ad-
ministeredtoassessglucosetolerancesta-
tus. During the second baseline visit,
insulin sensitivity and insulin secretion
were determined using a frequently sam-
pled intravenous glucose tolerance test
(11). An injection of regular insulin was
used to ensure adequate plasma insulin
levels for the accurate computation of in-
sulin sensitivity across a broad range of
glucose tolerance. The SI was calculated
using mathematical modeling methods
(MINMOD version 3.0, 1994; Los Ange-
les, CA, courtesy of Richard Bergman,
PhD) (12). The ﬁrst-phase insulin secre-
tion (AIR) was calculated as the mean of
2- and 4-min insulin concentrations after
glucose administration.
Race/ethnicity was assessed by self-
report. Family history of diabetes was de-
ﬁned as diabetes in parents or siblings.
Height and weight were measured to the
nearest 0.5 cm and 0.1 kg, respectively.
Waist circumference was measured to the
nearest 0.5 cm using a steel tape. Dupli-
cate measures of anthropometry were
made following a standardized protocol,
and averages were used in the analysis.
Plasma glucose concentration was deter-
mined by the glucose oxidase method
with a Beckman glucose analyzer. Plasma
insulin concentration was determined by
the dextran-charcoal radioimmunoassay.
This assay displays a high degree of cross-
reactivity with proinsulin.
We used the 1999 World Health Or-
ganization criteria to deﬁne diabetes and
IGT. Fasting glucose concentration 7.0
mmol/l and/or 2-h plasma glucose con-
centration 11.1 mmol/l was indicative
of diabetes. Subjects treated with hypogly-
cemic medications were also considered to
have diabetes. In the absence of diabetes,
IGT was deﬁned as a 2-h plasma glucose
level between 7.8 and 11.1 mmol/l.
Statistical analyses
The analysis was performed using SAS
statisticalsoftware(version9.1;SASInsti-
tute, Cary, NC). Baseline means  SD or
proportions were calculated for subjects
by diabetes status at the follow-up exam-
ination with use of t tests or 
2 tests to
assess the statistical signiﬁcance of differ-
ences. The relationship among plasma
glucose levels, SI, insulin secretion, and
measures of obesity was examined by
Spearmanpartialcorrelationanalysis.Co-
efﬁcients were adjusted for age, sex, eth-
nicity, and center. The relation of SI and
AIR to risk of incident diabetes was as-
sessedbylogisticregressionanalysis,with
diabetes status at the follow-up examina-
tion as the outcome variable. In addition,
odds ratios (ORs) were expressed for bi-
nary traits or per SD increase for contin-
uous traits. Unadjusted and adjusted ORs
were calculated for demographic vari-
ables(e.g.,age,sex,ethnicity,andclinical
center) as well as BMI and baseline glu-
cosetolerancestatus.Weassessedtheim-
pact of age, sex, ethnicity, BMI, family
history of diabetes, and glucose tolerance
statusontherelationofSIandAIRtocon-
version to type 2 diabetes by including
interaction terms in separate logistic re-
gression models. Log-transformed values
oflevelsoffastingand2-hinsulinandAIR
were used to improve discrimination and
calibrationofthemodelsandtominimize
theinﬂuenceofextremeobservations.We
also used the log transformation of (SI 	
1), given that some participants had SI 
0. These variables were then back-
transformed to their units for presenta-
tion in tables.
RESULTS— Duringthe5-yearfollow-
up period, 128 (15.5%) of 826 IRAS par-
ticipants developed type 2 diabetes: 44
(7.9%) of 557 participants with NGT at
baseline and 84 (31.2%) of 269 partici-
pants with IGT at baseline. Those con-
verting to type 2 diabetes did not differ
fromnonconvertersintermsofsexoreth-
nicity (Table 1). Older age and family his-
tory of diabetes were more common
among converters. Converters had also
higherBMIandwaistcircumferencemea-
surements,higherfastingand2-hglucose
and insulin values, and lower SI and AIR.
In Spearman partial correlation analy-
sis, SI was negatively related to fasting glu-
cose(r
0.33),2-hglucose(r
0.49),
BMI (r 
 0.53), and waist circumference
(r 
 0.56) after adjustment for age, sex,
race/ethnicity, and center (all P  0.001).
AIR was also negatively associated with SI
(r
 0.33, P0.001), fasting glucose (r

0.19, P  0.001), and 2-h glucose (r 

0.10,P0.004)but was positivelyasso-
ciated with BMI (r  0.22, P  0.001)
and waist circumference (r  0.23, P 
0.001).
Participants were stratiﬁed by tertiles
ofSIandAIR.BothSI(Ptrend0.001)and
AIR (Ptrend  0.001) predicted future de-
velopment of diabetes even after adjust-
ment for age, sex, ethnicity, center, IGT,
family history of diabetes, and BMI (Fig.
1). Risk of diabetes was highest in indi-
viduals in the lowest tertile of both SI and
AIR. No one in the highest tertile of both
SI and AIR developed type 2 diabetes.
Similar results were obtained in a multi-
variate logistic regression model with SI
and AIR as continuous traits (Table 2).
Replacing fasting and 2-h glucose for IGT
demonstrated that fasting and 2-h glu-
cose,SI,andAIRwereindependentlypre-
dictors of incident diabetes. Replacing
waist circumference for BMI rendered
similar results for both SI (OR  1 SD 0.64
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(0.66 [0.51–0.86], P  0.002). Neither
BMI(1.16[0.92–1.48])norwaistcircum-
ference (1.07 [0.83–1.39)] was an inde-
pendent risk factor in fully adjusted
models.
Inseparatelogisticregressionmodels,
we included appropriate interaction
terms to test the impact of age, sex, race/
ethnicity, BMI, family history of diabetes,
and glucose tolerance status on the rela-
tion of SI and AIR to conversion to type 2
diabetes. Age, sex, race/ethnicity, center,
BMI, glucose tolerance status, family his-
tory of diabetes, SI, and AIR were all in-
cluded as independent variables in all
models. None of the variables had a sig-
niﬁcant interaction on the relationship
between SI and conversion to diabetes
(P  0.15) or between AIR and conver-
sion to diabetes (P  0.20). The strength
of the relation of SI and AIR to conversion
to diabetes did not differ among catego-
riesofage,sex,race/ethnicity,glucosetol-
erance status, BMI, and family history of
diabetes (Fig. 2A–F). In addition, the in-
teraction term SI  AIR was not statisti-
cally signiﬁcant (P  0.42). AIR was an
independent risk factor across different
degreesofinsulinsensitivityandsowasSI
acrossvariousdegreesofinsulinsecretion
(Fig. 2G and H).
CONCLUSIONS — In three ethnic
groups, two of which are at high risk for
type 2 diabetes (African Americans, n 
206;non-Hispanicwhites,n288),both
SI and AIR predicted the development of
future diabetes. The observation that in-
sulin resistance measured directly pre-
dicts type 2 diabetes has been described
in offspring of white parents who both
hadtype2diabetes(5).Asecretorydefect
of insulin along with insulin resistance
has also been described in the high-risk
Pima Indians (7,9), Dutch white individ-
uals with IGT (9), and ﬁrst-degree rela-
tives of African Americans with type 2
diabetes (9). However, none of these
studiesadjustedforobesityorglucosetol-
erance,whichareassociatedwithbothin-
sulin resistance and secretion at baseline.
Our results indicate that both insulin re-
sistance and -cell dysfunction predict
diabetes even after adjustment for both
obesity and glucose tolerance. Thus, our
study validates previous studies and ex-
tendstheﬁndingstoHispanicandAfrican
American ethnic groups.
Someinvestigatorshavereportedthat
a large proportion of individuals with
type 2 diabetes among African Americans
present only with a defect in insulin se-
cretion (13). In IRAS, the proportion of
insulin-sensitive diabetic subjects is small
in all racial/ethnic groups (14). Differ-
ences in insulin resistance according to
race/ethnicity cannot be fully explained
byobesity,butnondiabeticAfricanAmer-
icanstendtohavelowerSIandhigherAIR
than their non-Hispanic white counter-
parts (15,16). Hispanics have also lower
SI and higher AIR than non-Hispanic
whites(15).Nevertheless,theroleofrace/
ethnicity (more speciﬁcally the role of ge-
netic determinants) on SI and AIR
remains to be elucidated (17,18). In the
current study, we were unable to detect
differences according to race/ethnicity in
the relation of SI and AIR to incident dia-
betes. Therefore, both insulin resistance
and secretion are important risk factors
for development of diabetes across racial/
ethnic groups.
Figure 1—Five-year incidence of diabetes by tertiles of SI and AIR. Results were adjusted for age,
sex,ethnicity,center,IGT,familyhistoryofdiabetes,andBMI.CutpointsfortertilesofSI(10

4
minutepermicrounitpermilliliter):lower,1.16;middle,1.17–2.38;andupper,2.39(Ptrend
0.001).CutpointsfortertilesofAIR(microunitspermilliliter):lower,37.5;middle,38.0–75.0;
and upper, 75.5 (Ptrend  0.001). Numerators and denominators for each cell are number of
participants who converted to diabetes and total number of participants at risk, respectively.
Table 1—Baseline demographic, anthropometric, and metabolic characteristics of partici-
pants without diabetes at baseline by conversion to diabetes at 5-year follow-up
Converters Nonconverters P
n 128 698
Female sex (%) 59.4 (50.7–67.5) 55.4 (51.7–59.1) 0.410
Ethnicity (%) 0.647
Non-Hispanic whites 39.1 (31.0–47.8) 40.4 (36.8–44.1)
African Americans 22.7 (16.2–30.7) 25.4 (22.3–28.7)
Hispanics 38.3 (30.3–47.0) 34.2 (30.8–37.8)
IGT (%) 65.6 (57.0–73.3) 26.5 (23.4–29.9) 0.001
Family history of diabetes (%) 50.0 (41.4–58.6) 38.5 (35.0–42.2) 0.016
Age (years) 56.5  8.1 54.4  8.5 0.009
BMI (kg/m
2) 30.8  6.1 27.8  5.3 0.001
Waist circumference (cm) 95.2  12.0 89.3  12.3 0.001
Fasting glucose (mmol/l) 5.83  0.55 5.35  0.54 0.001
2-h glucose (mmol/l) 8.42  1.69 6.60  1.73 0.001
Fasting insulin (pmol/l)* 105.3  98.6 70.9  59.8 0.001
2-h insulin (pmol/l)* 611.6  603.9 390.7  515.4 0.001
SI ( 10

4 min

1   U

1   ml

1)* 1.06  1.10 1.92  2.00 0.001
AIR (U/ml)* 37.6  43.8 53.0  62.4 0.001
Data are n, % (95% CI), or means  SD. P values were derived from 
2 or t tests, as appropriate. *Log-
transformed variables. These variables were then back-transformed to their units for presentation in the
table.
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a poor predictor of type 2 diabetes in in-
dividuals with no family history of the
disease. In this study, however, the inci-
dence of diabetes was low with only six
incident cases among 181 individuals
during a mean follow-up period of 25
years. Older work from Pima Indians also
suggested,onthebasisof2-hinsulin,that
insulin resistance was more important in
predicting the conversion to diabetes
from IGT but not from NGT (19). How-
ever, our results indicate that both SI and
AIR are independent determinants of di-
abetes regardless of family history of dia-
betes or glucose tolerance status.
In a report from the UK Prospective
Diabetes Study, leaner and younger dia-
betic subjects had higher rates of treat-
ment failure than their obese and older
counterparts (20). Because this ﬁnding
suggests that the primary defect in nor-
mal-weight individuals with diabetes is a
secretory defect, some treatment guide-
lines have recommended using met-
formin as a ﬁrst-line treatment in
overweight patients and either sulfonyl-
urea or metformin in normal-weight pa-
tients (21). A secretory defect, however,
may not be the only relevant anomaly in
most lean and young individuals who
develop diabetes. Ong et al. (22) have
shown that obesity does not modify the
glycemic response to metformin in type 2
diabetes. Our results also suggest that the
relation of insulin resistance and insulin
secretion to conversion to diabetes is sim-
ilar across categories of BMI and age.
Studies that use surrogate measures
of insulin resistance and -cell function
Figure 2—Risk of developing diabetes associated with SI and AIR by ethnicity, sex, glucose tolerance status, BMI and age categories, and family
historyofdiabetes.Estimatesareexpressedfora1-SDunitchange.Age,sex,ethnicity,center,BMI,IGT,familyhistoryofdiabetes,SI,andAIRwere
all included as independent variables in all eight models. Log-transformed values of SI and AIR were used to improve discrimination and calibration
of the models and to minimize the inﬂuence of extreme observations.
Table 2 —Predictors of conversion to type 2 diabetes by multiple logistic regression analysis
OR (95% CI) P
Model 1*
Age ( 1 SD) 1.09 (0.87–1.36) 0.468
Female vs. male 1.04 (0.66–1.63) 0.868
Family history of diabetes (yes vs. no) 1.27 (0.82–1.97) 0.283
IGT vs. NGT 2.39 (1.48–3.84) 0.001
BMI ( 1 SD) 1.29 (1.03–1.61) 0.024
SI ( 1 SD)† 0.50 (0.37–0.68) 0.001
AIR ( 1 SD)† 0.51 (0.40–0.65) 0.001
Model 2‡
Age ( 1 SD) 1.10 (0.87–1.38) 0.426
Female vs. male 1.17 (0.73–1.86) 0.522
Family history of diabetes (yes vs. no) 1.25 (0.80–1.96) 0.325
Fasting glucose ( 1 SD) 1.51 (1.16–1.96) 0.002
2-h glucose ( 1 SD) 1.93 (1.46–2.56) 0.001
BMI ( 1 SD) 1.16 (0.92–1.48) 0.211
SI ( 1 SD)† 0.66 (0.48–0.91) 0.010
AIR ( 1 SD)† 0.65 (0.50–0.85) 0.001
ORs are expressed for binary traits or per 1-SD unit change for continuous traits. *Results in model 1 were
adjustedalsoforethnicity(P0.343)andclinicalcenter(P0.064).†Log-transformedvariables.‡Results
in model 2 were adjusted also for ethnicity (P  0.393) and clinical center (P  0.051).
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lin secretion are major determinants of
type 2 diabetes (1–4). Lyssenko et al. (4)
have shown that longitudinal changes in
insulin resistance and insulin secretion in
converters as measured by homeostasis
model assessment of insulin resistance
and secretion are greater than changes in
nonconverters. Furthermore, the key ele-
ment for the onset of diabetes is the in-
abilityofthe-cellstocompensateforthe
change in insulin resistance (4,23). Our
study is novel because it highlights the
relevance of both insulin resistance and
-cell dysfunction in different ethnic
groups and various states of glucose tol-
erance, family history of diabetes, and
obesity. Our results also indicate that insu-
lin secretion is an independent risk factor
acrossdifferentdegreesofinsulinresistance
and so is insulin resistance across various
degrees of insulin secretion.
Our study has several limitations. We
expressedinsulinsecretionasthemeanof
2- and 4-min insulin concentrations after
glucose administration, reﬂecting ﬁrst-
phase insulin secretion. Thus, we have no
information on alternative aspects of
-cell function such as second-phase in-
sulin secretion, potentiation of insulin re-
lease by glucose, or the pulsatility and
oscillation of insulin secretion.
Insummary,consistentwiththemul-
tifactorial nature of diabetes suggested by
extant genetic studies (17,18,24), our re-
sults indicate that both insulin sensitivity
and -cell function are important deter-
minants of future diabetes in different
ethnic groups and various states of glu-
cose tolerance, family history of diabetes,
and obesity. Therefore, our ﬁndings indi-
cate that the prevention of type 2 diabetes
should focus on interventions that im-
prove both insulin resistance and insulin
secretion. Prevention approaches should
notdifferinnon-Hispanicwhites,African
Americans, and Hispanics. These conclu-
sions are reinforced by the results of the
Diabetes Prevention Program study (25),
which showed similar beneﬁt across eth-
nic groups. Therapeutic approaches may
be also useful in individuals with a broad
range of established risk factors including
age, sex, obesity, glucose tolerance status,
and family history of diabetes.
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